OncoTherapy Science, Inc.

TSE:4564.T

32 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income -1,288.138-1,116.42-2,570.306-1,560.012-2,236.997-3,194.655-2,919.262-2,997.571-2,789.446-1,361.918-3,715.731-1,129.4241,275.272616.992574.3183.631-228.295-1,327.453-544.60242.723
Depreciation & Amortization 0016.5449.00839.745391.998148.65789.653125.933106.32399.765135.684143.226156.978119.016120.003114.544118.438111.06556.275
Deferred Income Tax 00545.37700000064.494345.862-836.423-90.3626.0257.75864.33339.65675.03160.847-221.296
Stock Based Compensation 7.65531.33539.38400000010.14786.709319.165242.217270.124154.52652.96424.8890.090.5060.391
Change In Working Capital -106.517339.752-61.048-175.125-116.509165.046-158.329-31.21730.905-176.4871,586.9321,276.028-1,807.171-577.791177.641-522.027319.44644.33-50.104456.443
Accounts Receivables -15.187276-247-123-12-16-54.052-1.7911.791221,3221,44300000000
Inventory 25.618131.423-189.974-16.1380.402-10.773-1.5482.7676.2224.301-0.263-2.5071.6379.34514.526-1.935-21.463-17.73815.792-19.838
Accounts Payables 00000000000000000000
Other Working Capital -116.948-67.671375.926-35.987-104.911191.819-156.781-33.98424.683-180.7881,587.1951,278.535-1,808.808-587.136163.115-520.092340.90962.068-65.896476.281
Other Non Cash Items 156.234-49.568-43.171-76.538.232264.184-107.013-48.905-265.678-345.166-53.204-220.684145.493-31.367-8.635-22.40875.985-1.933-128.61-55.463
Operating Cash Flow -1,227.99-794.901-2,073.224-1,762.629-2,275.529-2,373.427-3,035.947-2,988.04-2,898.286-1,702.607-1,649.667-455.654-91.325440.9611,024.616-223.504346.225-1,091.497-550.898279.073
Investing Activities:
Investments In Property Plant And Equipment -2.627-5.393-456.949-43.914-131.378-71.349-408.888-11.957-116.643-56.284-41.282-54.588-60.277-241.92-121.792-147.453-104.423-88.482-401.691-186.296
Acquisitions Net 00.4760.0490.049102.703015000-59.30000000-41.918-95.1280
Purchases Of Investments 000000000-59.30000000-7,520.831-1,999.445-4,999.445
Sales Maturities Of Investments 0000000010,999.99849.2720450003,000713.9053,996.4856,998.8910
Other Investing Activites -30.728-15.402-11.028-8.36-2.025-2.858-37.533-0.00110,999.9982,010.026-12,999.426-0.2633,501.109-503.403-3,004.8643,050.037-3,049.84541.71295.177-101.568
Investing Cash Flow -33.354-20.319-467.928-52.225-30.7-74.207-446.421-11.95810,883.3551,884.414-13,040.708-9.8513,440.832-745.323-3,126.6565,902.584-2,440.363-3,613.0344,597.804-5,287.309
Financing Activities:
Debt Repayment -4.64200000000000000-126.7810000
Common Stock Issued 682.55201,466.71702,164.089553.9580.642.3312.44568.46711,017.17724.60625.76771.44224.52819.21835.2313.0141.02719.703
Common Stock Repurchased -6.540000000000000000000
Dividends Paid 00000000000000000000
Other Financing Activities -0.00295.9512.2502,16412.0131502126811,0172400015.731111.051000
Financing Cash Flow 671.36595.951,478.96702,164.089565.971150.642.3312.44568.46711,017.17724.60625.76771.44224.528-91.832146.28113.0141.02719.703
Other Information:
Effect Of Forex Changes On Cash 0-0.001-0.0010-1.582-0.903-0.9950.3370.973-3.5311.1970.419-0.2744.3710.2350.1650.001-0.0010.0010
Net Change In Cash -589.979-719.271-1,062.186-1,814.855-143.723-1,882.568-3,332.724-2,997.3327,998.487246.744-3,672.002-440.4813,375-228.547-2,077.2775,587.412-1,947.856-4,691.5224,087.934-4,988.533
Cash At End Of Period 527.6561,117.6351,836.9062,899.0924,713.9474,857.676,740.23810,072.96213,070.2945,071.8074,825.0638,497.0658,937.5465,562.5465,791.0937,868.372,280.9584,228.8148,920.3364,832.402